Literature DB >> 10564589

At least five regions of imbalance on 6q in breast tumors, combining losses and gains.

C Rodriguez1, A Causse, E Ursule, C Theillet.   

Abstract

The long arm of chromosome 6 is frequently rearranged in human cancer. In breast cancer, allelotyping studies have indicated the existence of three to four distinct regions of allelic imbalance. Chromosome transfer studies have shown the presence of several growth inhibiting or senescence promoting genes in the segment between 6q13 and 6q27. Moreover, results from comparative genomic hybridization (CGH) analyses have indicated that 6q was indeed a site of chromosomal losses, but that it was also involved in a substantial number of gains. In the present work, we allelotyped 178 pairs of breast tumor and normal tissue DNAs using 30 CA repeat markers from the Genethon collection. Seventy-six percent of the tumors in our panel displayed allelic imbalance (AI) of at least one locus, but patterns of AI could be complex. Whereas 11 tumors showed AI at all markers tested, 57 presented zebra profiles, and 28 showed AI at one site only. We characterized five distinct domains of AI defined, from centromere to telomere, by D6S300 (domain 1), D6S434 (domain 2), D6S261 (domain 3), D6S314-D6S409 (domain 4), and D6S441-D6S415 (domain 5). Some of the domains could be narrowed down to intervals of 1cM or less. We performed CGH analysis on a subset of 34 tumors presenting AI of variable extent at 6q. In 10/34 tumors, CGH did not reveal any anomaly on 6q. Most of these presented AI on short intervals, thus being below the detection threshold by CGH. Of the remaining 24 tumors presenting anomalies by CGH, 11 presented gains involving all or portions of 6q and 15 losses (2 presented combined losses and gains). By CGH, the 6q21-22 region was most commonly involved in gains, whereas 6q13-14 and 6q25-27 were frequently lost. Thus, allelic imbalances on 6q can either represent a gain or a loss depending on the region involved. Genes Chromosomes Cancer 27:76-84, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10564589

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  19 in total

1.  Expression of MTLC gene in gastric carcinoma.

Authors:  Guang-Bin Qiu; Li-Guo Gong; Dong-Mei Hao; Zhi-Hong Zhen; Kai-Lai Sun
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

2.  Genetic characterisation of invasive breast cancer: a comparison of CGH and PCR based multiplex microsatellite analysis.

Authors:  H Buerger; H Schmidt; A Beckmann; K S Zänker; W Boecker; B Brandt
Journal:  J Clin Pathol       Date:  2001-11       Impact factor: 3.411

Review 3.  Matricellular CCN6 (WISP3) protein: a tumor suppressor for mammary metaplastic carcinomas.

Authors:  Mai N Tran; Celina G Kleer
Journal:  J Cell Commun Signal       Date:  2018-01-22       Impact factor: 5.782

4.  Undetectable and Decreased Expression of KIAA1949 (Phostensin) Encoded on Chromosome 6p21.33 in Human Breast Cancers Revealed by Transcriptome Analysis.

Authors:  Yan A Su; Jun Yang; Lian Tao; Hein Nguyen; Ping He
Journal:  J Cancer       Date:  2010-06-21       Impact factor: 4.207

5.  Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma.

Authors:  Xiaomei Zhang; Yunsheng Yang; Xuefeng Liu; James G Herman; Malcolm V Brock; Julien D F Licchesi; Wen Yue; Xuetao Pei; Mingzhou Guo
Journal:  Epigenetics       Date:  2013-02-28       Impact factor: 4.528

Review 6.  Canine cytogenetics--from band to basepair.

Authors:  M Breen
Journal:  Cytogenet Genome Res       Date:  2008-04-30       Impact factor: 1.636

7.  The emerging role of CCN6 in breast cancer invasion.

Authors:  Guadalupe Lorenzatti; Wei Huang; Celina G Kleer
Journal:  Cellscience       Date:  2009-10

8.  Implication of snoRNA U50 in human breast cancer.

Authors:  Xue-Yuan Dong; Peng Guo; Jeff Boyd; Xiaodong Sun; Qunna Li; Wei Zhou; Jin-Tang Dong
Journal:  J Genet Genomics       Date:  2009-08       Impact factor: 4.275

9.  Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway.

Authors:  Shangqin Guo; Gail E Sonenshein
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

10.  On how CCN6 suppresses breast cancer growth and invasion.

Authors:  Wei Huang; Anupama Pal; Celina G Kleer
Journal:  J Cell Commun Signal       Date:  2011-08-13       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.